Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
8.66M
-
Shares change
-
-44.9K
-
Total reported value, excl. options
-
$3.39M
-
Value change
-
-$48.1K
-
Put/Call ratio
-
0.01
-
Number of buys
-
8
-
Number of sells
-
-9
-
Price
-
$0.39
Significant Holders of Equillium, Inc. - COM (EQ) as of Q1 2025
29 filings reported holding EQ - Equillium, Inc. - COM as of Q1 2025.
Equillium, Inc. - COM (EQ) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.66M shares
.
Largest 10 shareholders include Decheng Capital LLC (4.45M shares), TAKEDA PHARMACEUTICAL CO LTD (1.82M shares), VANGUARD GROUP INC (842K shares), Cota Capital Management, LLC (562K shares), RENAISSANCE TECHNOLOGIES LLC (270K shares), GEODE CAPITAL MANAGEMENT, LLC (205K shares), ACADIAN ASSET MANAGEMENT LLC (109K shares), Callan Capital, LLC (99.7K shares), STATE STREET CORP (59.7K shares), and CITADEL ADVISORS LLC (55.6K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.